Sofinnova Investments’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Sofinnova Investments’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-48,998	Closed	-$6.68M	–	88
2020 Q3	$6.68M	Sell	48,998 -62,812	-56%	-$6.68M	0.5%	39
2020 Q2	$10.8M	Sell	111,810 -63,308	-36%	-$5.28M	0.68%	34
2020 Q1	$8.21M	Sell	175,118 -20,753	-11%	-$1.33M	0.76%	25
2019 Q4	$14.3M	Buy	195,871 +81,945	+72%	+$4.97M	1.03%	21
2019 Q3	$5.94M	Buy	+113,926	New	+$6.06M	0.54%	39

Sofinnova Investments's MYOK Position: Q4 2020 in Review

Sofinnova Investments sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 48,998 shares — an estimated $6.68M sold.

Sofinnova Investments first reported a position in MYOK in Q3 2019 and held it in 5 quarters. The position peaked at $14.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Sofinnova Investments reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Sofinnova Investments sold 48,998 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $6.68M.
Sofinnova Investments first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Sofinnova Investments's MyoKardia, Inc. Common Stock position peaked at $14.3M in Q4 2019.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Sofinnova Investments's 13F filing for Q4 2020, filed 16 Feb 2021.